Patent · US Active

Compositions and methods for treating hyperkalemia

US9867848B2 · kind B2 · utility

0Cited by

3References

26Claims

0Family size

Assignee

ARDELYX, INC. · US

Inventors

Dominique Charmot · Campbell, US
James P. Davidson · Mountain View, US
Fangling Lin · Belmont, US
Jeffrey W. Jacobs · Fremont, US
Natalia Blinova · Berkeley, US
Eric Labonte · Redwood City, US
Ingrid Langsetmo · Golden Valley, US
Robert C. Blanks · Waltham, US

Key dates

Filing date	Mar 29, 2017
Grant date	Jan 16, 2018
Priority date	—
Expiry date	Mar 29, 2037

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC08F12/30
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention is directed to compositions and methods of removing potassium or treating hyperkalemia by administering pharmaceutical compositions of cation exchange polymers with low crosslinking for improved potassium excretion and for beneficial physical properties to increase patient compliance.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.